Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Janine Beck
Low Expression of Aldehyde Deyhdrogenase 1A1 (ALDH1A1) Is a Prognostic Marker for Poor Survival in Pancreatic Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
High ALDH1A1 Expression Correlates With Poor Survival in Papillary Thyroid Carcinoma
World Journal of Surgical Oncology
Surgery
Oncology
Tetraspanin CD151 Is a Novel Prognostic Marker in Poor Outcome Endometrial Cancer
British Journal of Cancer
Cancer Research
Oncology
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
The Anatomic Location of Pancreatic Cancer Is a Prognostic Factor for Survival
HPB
Hepatology
Gastroenterology
Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer
PLoS ONE
Multidisciplinary
CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival
American Journal of Pathology
Forensic Medicine
Pathology
C-Met Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
Clinical Colorectal Cancer
Oncology
Gastroenterology
Aldehyde Dehydrogenase 1A1 Expression in Breast Cancer Is Associated With Stage, Triple Negativity, and Outcome to Neoadjuvant Chemotherapy
Modern Pathology
Forensic Medicine
Pathology